123 I-MIBG scintigraphy in the assessment of heart failure prognosis and effectiveness of cardiac resynchronization therapy

Cardiac resynchronization therapy (CRT) is one of the methods of treating patients with chronic heart failure, which can reduce the mortality rate of this group. Scintigraphic assessment of sympathetic myocardial innervation allows us to evaluate the heart failure prognosis and the effectiveness of interventional treatment. The method is based on use of the radiopharmaceutical 123 I-methiodiobenzylguanidine (123 I-MIBG), which is a structural analogue of norepinephrine and is able to selectively accumulate in the sympathetic nerve endings. This review includes a brief description of norepinephrine metabolism and pharmacokinetics of 123 I-MIBG in the sympathetic nerve ending, a brief description of the study methodology and the clinical significance of this method in patients with heart failure. Particular attention is paid to the possibilities of using this method in patients with severe chronic heart failure before and after CRT.

123I-MIBG, heart failure, resynchronization therapy, CRT

1. Cleland JGF, Freemantle N, Erdmann E, Gras D, Kappenberger L, Tavazzi L et al. Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. European Journal of Heart Failure. 2012;14(6):628–34. DOI: 10.1093/eurjhf/hfs055

2. Frolova E.B., Yaushev M.F. Current understanding of chronic heart failure. Bulletin of Contemporary Clinical Medicine. 2013;6(2): 87–93.

3. Polyakov D.S., Fomin I.V., Valikulova F.Yu., Vaisberg A.R., Kraiem N., Badin Yu.V. et al. The EPOCHA-CHF epidemiological program: decompensated chronic heart failure in real-life clinical practice (EPOCHA-D-CHF). Russian Heart Failure Journal. 2016;17 (5):299– 305. DOI: 10.18087/rhfj.2016.5.2239

4. Mareev Yu.V., Gerasimova V.V., Goriunova T.V., Petrukhina A.A., Danielian M.O., Kapanadze L.G. et al. Factors defining the prognosis in chronic heart failure: role of the QRS width and morphology. Russian Heart Failure Journal. 2012;13 (5):255–66.

5. López-Sendón J. The heart failure epidemic. Medicographia. 2011;33(4):363–9. Av. at: https://www.medicographia.com/2012/02/the-heart-failure-epidemic/.2012.

6. Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A. et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8–164. DOI: 10.18087/cardio.2475

7. Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK et al. Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients with Advanced Heart Failure: Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2009;119(7):969–77. DOI: 10.1161/CIRCULATIONAHA.108.793273

8. Tang ASL, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. New England Journal of Medicine. 2010;363(25):2385–95. DOI: 10.1056/NEJMoa1009540

9. Esler M, Kaye D, Lambert G, Esler D, Jennings G. Adrenergic Nervous System in Heart Failure. The American Journal of Cardiology. 1997;80(11):7L-14L. DOI: 10.1016/S0002-9149(97)00844-8

10. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The Sympathetic Nervous System in Heart Failure. Journal of the American College of Cardiology. 2009;54(19):1747–62. DOI: 10.1016/j.jacc.2009.05.015

11. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA et al. Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure. Results of the Prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study. Journal of the American College of Cardiology. 2010;55(20):2212–21. DOI: 10.1016/j.jacc.2010.01.014

12. Marshall A, Cheetham A, George RS, Mason M, Kelion AD. Cardiaciodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention. Heart. 2012;98(18):1359–65. DOI: 10.1136/heartjnl-2012-302321

13. Shvalev V.N., Rogoza F.N., Tarsky N.A., Sergienko V.B., Ansheles A.A., Reutov V.P. et al. Sudden cardiac death and morphofunctional diagnostics previous age neurotrophic changes of organisms. Pacific Medical Journal. 2017;1(67):42–51.

14. Nakajima K, Nakata T. Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan. Journal of Nuclear Medicine. 2015;56(Suppl 4):11S-19S. DOI: 10.2967/jnumed.114.142794

15. Merlet P, Pouillart F, Dubois-Randé JL, Delahaye N, Fumey R, Castaigne A et al. Sympathetic nerve alterations assessed with 123IMIBG in the failing human heart. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 1999;40(2):224–31. PMID: 10025827

16. Chen X, Werner RA, Javadi MS, Maya Y, Decker M, Lapa C et al. Radionuclide Imaging of Neurohormonal System of the Heart. Theranostics. 2015;5(6):545–58. DOI: 10.7150/thno.10900

17. Patel A. MIBG imaging. Journal of Nuclear Cardiology. 2002;9(1): 75–94. DOI: 10.1067/mnc.2002.121471

18. Lishmanov Yu.B., Zavadovsky K.V., Efimova I.Yu., Krivonogov N.G., Vesnina Zh.V., Sazonova S.I. et al. Prospects of nuclear medicine for the diagnosis of cardiovascular diseases. Siberian Medical Journal (Tomsk). 2015;30 (2):21–9.

19. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD et al. Agreement Is Poor Among Current Criteria Used to Define Response to Cardiac Resynchronization Therapy. Circulation. 2010;121(18):1985–91. DOI: 10.1161/CIRCULATIONAHA.109.910778

20. van Bommel RJ, Bax JJ, Abraham WT, Chung ES, Pires LA, Tavazzi L et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. European Heart Journal. 2009;30(20):2470–7. DOI: 10.1093/eurheartj/ehp368

21. Wikstrom G, Blomstrom-Lundqvist C, Andren B, Lonnerholm S, Blomstrom P, Freemantle N et al. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. European Heart Journal. 2008;30(7):782–8. DOI: 10.1093/eurheartj/ehn577

22. Vallsbertault V. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace. 2004;6(5):438–43. DOI: 10.1016/j.eupc.2004.04.004

23. Miyazaki C, Redfield MM, Powell BD, Lin GM, Herges RM, Hodge DO et al. Dyssynchrony Indices To Predict Response to Cardiac Resynchronization Therapy: A Comprehensive Prospective SingleCenter Study. Circulation: Heart Failure. 2010;3(5):565–73. DOI: 10.1161/CIRCHEARTFAILURE.108.848085

24. Fulati Z, Liu Y, Sun N, Kang Y, Su Y, Chen H et al. Speckle tracking echocardiography analyses of myocardial contraction efficiency predict response for cardiac resynchronization therapy. Cardiovascular Ultrasound. 2018;16(1):30. DOI: 10.1186/s12947-018-0148-5

25. Bax JJ, Gorcsan J. Echocardiography and Noninvasive Imaging in Cardiac Resynchronization Therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. Journal of the American College of Cardiology. 2009;53(21):1933–43. DOI: 10.1016/j.jacc.2008.11.061

26. Sassone B, Nucifora G, Mele D, Valzania C, Bisignani G, Boriani G. Role of cardiovascular imaging in cardiac resynchronization therapy: a literature review. Journal of Cardiovascular Medicine. 2018;19(5):211–22. DOI: 10.2459/JCM.0000000000000635

27. Lebedev D.I., Krivolapov S.N., Zavadovsky K.V., Sazonova S.I., Karpov R.S., Popov S.V. Right ventricle myocardium contractility asparameter of cardiac resynchronization efficacy. Russian Journal of Cardiology. 2017;22 (7):87–92. DOI: 10.15829/1560-4071-2017-7-87-92

28. Gulya M.O., Lishmanov Yu.B., Zavadovsky K.V., Lebedev D.I. Metabolism of fatty acids in left ventricle myocardium and the efficacy prognosis of cardio-resynchronizing therapy in dilated cardiomyopathy patients. Russian Journal of Cardiology. 2014;19 (9):61–7. DOI: 10.15829/1560-4071-2014-9-61-67-29.

29. Sartori C, Degiovanni A, Devecchi F, Devecchi P, Marino PN. Acute Modifications of Left Ventricular Torsional Mechanics Induced by Cardiac Resynchronization Therapy Affect Short-Term Reverse Remodeling. Circulation Journal. 2019;83(2):386–94. DOI: 10.1253/circj.CJ-18-0858

30. Lishmanov Yu.B., Zavadovsky K.V., Gulya M.O., Minin S.M., Lebedev D.I. Capabilities of myocardial perfusion-metabolism scintigraphy for prediction of cardiac resynchronization therapy outcomes in patients with dilated cardiomyopathy. Siberian Medical Journal (Tomsk). 2014;29(3):51–5.

31. Viveiros Monteiro A, Martins Oliveira M, Silva Cunha P, Nogueira da Silva M, Feliciano J, Branco L et al. Time to left ventricular reverse remodeling after cardiac resynchronization therapy: Better late than never. Revista Portuguesa de Cardiologia. 2016;35(3):161–7. DOI: 10.1016/j.repc.2015.11.008

32. Kuznetsov V. A., Soldatova A. M., Krinochkin D. V., Enina T. N. Cardiac resynchronisation therapy in patients with congestive heart failure: whether we should expect for an ‘early’ response? Russian Heart Failure Journal. 2017;18 (3):172–7. DOI: 10.18087/rhfj.2017.3.2341

33. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 1996;93(9):1667–76. DOI: 10.1161/01.cir.93.9.1667

34. Bengel FM. Imaging Targets of the Sympathetic Nervous System of the Heart: Translational Considerations. Journal of Nuclear Medicine. 2011;52(8):1167–70. DOI: 10.2967/jnumed.110.084228

35. Raffel DM, Wieland DM. Development of mIBG as a Cardiac Innervation Imaging Agent. JACC: Cardiovascular Imaging. 2010;3(1):111– 6. DOI: 10.1016/j.jcmg.2009.09.015

36. Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schaffers M et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. European Journal of Nuclear Medicine and Molecular Imaging. 2010;37(9):1802–12. DOI: 10.1007/s00259-010-1491-4

37. Ansheles A.A., Sergienko V.B. Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography. Journal of radiology and nuclear medicine. 2016;97(3):173–80. DOI: 10.20862/0042-4676-2016-97-3-173-180

38. Cha Y-M, Oh J, Miyazaki C, Hayes DL, Rea RF, Shen W-K et al. Cardiac Resynchronization Therapy Upregulates Cardiac Autonomic Control. Journal of Cardiovascular Electrophysiology. 2008;19(10): 1045–52. DOI: 10.1111/j.1540-8167.2008.01190.x

39. Gimelli A, Liga R, Giorgetti A, Genovesi D, Marzullo P. Assessment of myocardial adrenergic innervation with a solid-state dedicated cardiac cadmium-zinc-telluride camera: first clinical experience. European Heart Journal Cardiovascular Imaging. 2014;15(5):575–85. DOI: 10.1093/ehjci/jet258

40. Aarnoudse WH, Botman K-JB, Pijls NH. False-negative myocardial scintigraphy in balanced three-vessel disease, revealed by coronary pressure measurement. International Journal of Cardiovascular Interventions. 2003;5(2):67–71. DOI: 10.1080/14628840310003244

41. Mochula A.V., Zavadovsky K.V., Andreev S.L., Lishmanov Yu.B. Dynamic single-photon emission computed tomography as a method of identification of multivessel coronary artery disease. Journal of radiology and nuclear medicine. 2016;97(5):289– 95. DOI: 10.20862/0042-4676-2016-97-5-289-295

42. Ramchandra R, Hood SG, Denton DA, Woods RL, McKinley MJ, McAllen RM et al. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure. Proceedings of the National Academy of Sciences. 2009;106(3):924–8. DOI: 10.1073/pnas.0811929106

43. Morris MJ, Cox HS, Lambert GW, Kaye DM, Jennings GL, Meredith IT et al. Region-Specific Neuropeptide Y Overflows at Rest and During Sympathetic Activation in Humans. Hypertension. 1997;29(1):137–43. DOI: 10.1161/01.HYP.29.1.137

44. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P. Increased Cardiac Adrenergic Drive Precedes Generalized Sympathetic Activation in Human Heart Failure. Circulation. 1997;95(1):169–75. DOI: 10.1161/01.CIR.95.1.169

45. Narula J. A conceptual paradox of MIBG uptake in heart failure: retention with incontinence! Journal of Nuclear Cardiology. 2003;10(6):700–4. DOI: 10.1016/j.nuclcard.2003.09.006

46. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BLF. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. European Heart Journal. 2008;29(9):1147–59. DOI: 10.1093/eurheartj/ehn113

47. Regitz V, Leuchs B, Bossaller C, Sehested J, Rappolder M, Fleck E. Myocardial catecholamine concentrations in dilated cardiomyopathy and heart failure of different origins. European Heart Journal. 1991;12(suppl D):171–4. DOI: 10.1093/eurheartj/12.suppl_D.171

48. Zavadovsky KV, Gulya MO, Lishmanov YB, Lebedev DI. Perfusion and metabolic scintigraphy with 123I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy. Annals of Nuclear Medicine. 2016;30(5):325–33. DOI: 10.1007/s12149-016-1064-0

49. Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. Journal of Nuclear Medicine. 2001;42(12):1757–67. PMID: 11752070

50. Verschure DO, Veltman CE, Manrique A, Somsen GA, Koutelou M, Katsikis A et al. For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. European Heart Journal Cardiovascular Imaging. 2014;15(9):996– 1003. DOI: 10.1093/ehjci/jeu044

51. Clements IP, Kelkar AA, Garcia EV, Butler J, Chen J, Folks R et al. Prognostic significance of 123I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure. European Heart Journal – Cardiovascular Imaging. 2016;17(4):384–90. DOI: 10.1093/ehjci/jev295

52. Yamamoto H, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y et al. Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging. Journal of Nuclear Cardiology. 2019;26(1):109–17. DOI: 10.1007/s12350-017-0913-0

53. Schofer J, Spielmann R, Schuchert A, Weber K, Schlüter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 1988;12(5):1252–8. DOI: 10.1016/0735-1097(88)92608-3

54. Merlet P, Valette H, Dubois-Randé JL, Moyse D, Duboc D, Dove P et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. Journal of Nuclear Medicine. 1992;33(4):471–7. PMID: 1552326

55. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. Journal of Nuclear Medicine. 1997;38(7):1085–9. PMID: 9225795

56. Nishioka S, Martinellifilho M, Brandao S, Giorgi M, Vieira M, Costa R et al. Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy. Journal of Nuclear Cardiology. 2007;14(6):852–9. DOI: 10.1016/j.nu-clcard.2007.08.004

57. Burri H, Sunthorn H, Somsen A, Fleury E, Stettler C, Shah D et al. Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy. Europace. 2008;10(3):374–8. DOI: 10.1093/europace/eun017

58. Shinohara T, Takahashi N, Saito S, Okada N, Wakisaka O, Yufu K et al. Effect of Cardiac Resynchronization Therapy on Cardiac Sympathetic Nervous Dysfunction and Serum C-reactive Protein Level. Pacing and Clinical Electrophysiology. 2011;34(10):1225–30. DOI: 10.1111/j.1540-8159.2011.03156.x

59. Cha Y-M, Chareonthaitawee P, Dong Y-X, Kemp BJ, Oh JK, Miyazaki C et al. Cardiac Sympathetic Reserve and Response to Cardiac Resynchronization Therapy. Circulation: Heart Failure. 2011;4(3):339– 44. DOI: 10.1161/CIRCHEARTFAILURE.110.959858

60. Tanaka H, Tatsumi K, Fujiwara S, Tsuji T, Kaneko A, Ryo K et al. Effect of Left Ventricular Dyssynchrony on Cardiac Sympathetic Activity in Heart Failure Patients with Wide QRS Duration. Circulation Journal. 2012;76(2):382–9. DOI: 10.1253/circj.CJ-11-0752

61. Curcio A, Cascini GL, De Rosa S, Pasceri E, Veneziano C, Cipullo S et al. 123I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation. International Journalof Cardiology. 2016;207:107–9. DOI: 10.1016/j.ijcard.2016.01.131

62. Moreira RI, Abreu A, Portugal G, Oliveira L, Oliveira M, Rodrigues I et al. Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy. Journal of Nuclear Cardiology. 2018; [Epub ahead of print]. DOI: 10.1007/s12350-018-1357-x

63. Cruz MC, Abreu A, Portugal G, Santa-Clara H, Cunha PS, Oliveira MM et al. Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation as assessed by 123I-mIBG scintigraphy in patients with heart failure with reduced ejection fraction submitted to cardiac resynchronization therapy: Assessment of cardiac autonomic denervation by GLS in patients with heart failure with reduced ejection fraction submitted to CRT. Journal of Nuclear Cardiology. 2019;26(3):869–79. DOI: 10.1007/s12350-017-1148-9

64. Higuchi K, Toyama T, Tada H, Naito S, Ohshima S, Kurabayashi M. Usefulness of Biventricular Pacing to Improve Cardiac Symptoms, Exercise Capacity and Sympathetic Nerve Activity in Patients with Moderate to Severe Chronic Heart Failure. Circulation Journal. 2006;70(6):703–9. DOI: 10.1253/circj.70.703

65. Yonezawa M, Nagao M, Abe K, Matsuo Y, Baba S, Kamitani T et al. Relationship between impaired cardiac sympathetic activity and spatial dyssynchrony in patients with non-ischemic heart failure: Assessment by MIBG scintigraphy and tagged MRI. Journal of Nuclear Cardiology. 2013;20(4):600–8. DOI: 10.1007/s12350-013-9715-1